Human immunodeficiency virus per se exerts atherogenic effects

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 586-589

  Oliviero, Ugo ^a   Bonadies, Giovanni ^a   Apuzzi, Valentina ^a   Foggia, Maria ^a   Bosso, Giorgio ^a   Nappa, Salvatore ^a   Valvano, Antonio ^a   Leonardi, Enrico ^b   Borgia, Guglielmo ^a   Castello, Giuseppe ^b   Napoli, Raffaele ^a   Saccà, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Atherosclerosis; Carotid arteries; Endothelium; Risk factors; Viruses

Indexed keywords

ADULT; ARTERY DILATATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; VASCULAR PATENCY; VIRUS LOAD;

ADULT; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV; HIV INFECTIONS; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; RNA, VIRAL; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA; VASODILATION; VIRAL LOAD;

EID: 67349221763     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.10.012     Document Type: Article

References (16)

1. Palella Jr. F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
2. Holmberg S.D., Moorman A.C., Williamson J.M., et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360 (2002) 1747-1748
3. Schneider M.F., Gange S.J., Williams C.M., et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 18 (2005) 2009-2018
4. Bozzette S.A., Ake C.F., Tam H.K., Chang S.W., and Louis T.A. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348 (2003) 702-710
5. Friis-Moller N., Sabin C.A., Weber R., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
6. d'Arminio A., Sabin C.A., Phillips A.N., et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 18 (2004) 1811-1817
7. van Wijk J.P., de Koning E.J., Cabezas M.C., et al. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol 47 (2006) 1117-1123
8. Dhawan S., Puri R.K., Kumar A., et al. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood 90 (1997) 1535-1544
9. Park I.W., Ullrich C.K., Schoenberger E., Ganju R.K., and Groopman J.E. HIV-1 Tat induces microvascular endothelial apoptosis trough caspase activation. J Immunol 167 (2001) 2766-2771
10. Oliviero U., Orefice G., Coppola G., et al. Carotid atherosclerosis and ischemic stroke in young patients. Int Angiol 21 (2002) 117-122
11. De Groot E., Hovingh K., Wiegman A., et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 109 (2004) 33-38
12. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol 39 (2002) 257-265
13. Stein J.H., Klein M.A., Bellehumeur J.L., et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 104 (2001) 257-262
14. Hsue P.Y., Lo J.C., Franklin A., et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109 (2004) 1603-1608
15. Blum A., Hadas V., Burke M., Yust I., and Kessler A. Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction. Clin Cardiol 28 (2005) 149-153
16. Charakida M., Donald A.E., Green H., et al. Early structural and functional changes of the vasculature in HIV-infected children. Circulation 112 (2005) 103-109